Death Rattle for Defensives?
While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...
1k Views
Olympus - Is It All Going Wrong Again?
Olympus reported a poor 1Q FY16 OP result (¥10.8 billion down 37% YoY) and revised down its full year OP forecast (from ¥90 billion to ¥77...
203 Views
Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.7k Views
Ono & Opdivo: Is the Backlash Orchestrated?
The announcement by the Japan Society of Medical Oncology (JSMO) urging patients to take caution over usage of immune checkpoint inhibitors, such...
258 Views
OLYMPUS: Record Profit Falls Short, Forecasts Fall Shorter
Yesterday, Olympus Corp reported results (tanshin, presentation, full financial data) a record net profit for the group at 62.5bn yen and sales for...
193 Views